Russell Investments Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21K | Sell |
2,070
-2,867
| -58% | -$5.83K | ﹤0.01% | 3485 |
|
|
2025
Q1 | $8.05K | Buy |
+4,937
| New | +$8.05K | ﹤0.01% | 3281 |
|
|
2024
Q4 | – | Sell |
-1,733
| Closed | -$10K | – | 3750 |
|
|
2024
Q3 | $10K | Hold |
1,733
| – | – | ﹤0.01% | 3078 |
|
|
2024
Q2 | $14K | Hold |
1,733
| – | – | ﹤0.01% | 3005 |
|
|
2024
Q1 | $24.1K | Hold |
1,733
| – | – | ﹤0.01% | 2757 |
|
|
2023
Q4 | $10.6K | Hold |
1,733
| – | – | ﹤0.01% | 2820 |
|
|
2023
Q3 | $8.09K | Hold |
1,733
| – | – | ﹤0.01% | 3055 |
|
|
2023
Q2 | $9.29K | Hold |
1,733
| – | – | ﹤0.01% | 2976 |
|
|
2023
Q1 | $17.1K | Hold |
1,733
| – | – | ﹤0.01% | 2833 |
|
|
2022
Q4 | $32.4K | Hold |
1,733
| – | – | ﹤0.01% | 2763 |
|
|
2022
Q3 | $35K | Hold |
1,733
| – | – | ﹤0.01% | 2769 |
|
|
2022
Q2 | $35K | Hold |
1,733
| – | – | ﹤0.01% | 2754 |
|
|
2022
Q1 | $74K | Hold |
1,733
| – | – | ﹤0.01% | 2600 |
|
|
2021
Q4 | $103K | Hold |
1,733
| – | – | ﹤0.01% | 2835 |
|
|
2021
Q3 | $148K | Sell |
1,733
-805
| -32% | -$68.7K | ﹤0.01% | 2825 |
|
|
2021
Q2 | $282K | Hold |
2,538
| – | – | ﹤0.01% | 2804 |
|
|
2021
Q1 | $282K | Buy |
2,538
+697
| +38% | +$77.4K | ﹤0.01% | 2739 |
|
|
2020
Q4 | $195K | Sell |
1,841
-805
| -30% | -$85.3K | ﹤0.01% | 2764 |
|
|
2020
Q3 | $367K | Buy |
2,646
+1,841
| +229% | +$255K | ﹤0.01% | 2532 |
|
|
2020
Q2 | $260K | Buy |
+805
| New | +$260K | ﹤0.01% | 2623 |
|
|
2018
Q1 | – | Sell |
-1,570
| Closed | -$78K | – | 2943 |
|
|
2017
Q4 | $78K | Hold |
1,570
| – | – | ﹤0.01% | 2818 |
|
|
2017
Q3 | $119K | Sell |
1,570
-3,432
| -69% | -$260K | ﹤0.01% | 2753 |
|
|
2017
Q2 | $471K | Sell |
5,002
-1,474
| -23% | -$139K | ﹤0.01% | 2436 |
|
|
2017
Q1 | $514K | Sell |
6,476
-248
| -4% | -$19.7K | ﹤0.01% | 2415 |
|
|
2016
Q4 | $559K | Buy |
+6,724
| New | +$559K | ﹤0.01% | 2425 |
|